TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells - Concepedia

Concepedia

Publication | Open Access

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

DOI Full Paper Access

74

Citations

25

References

2014

Year

Mark Tuthill, Antonella Montinaro, Julia Zinngrebe, Katharina Prieske, Peter Dráber, Silvia Prieske, Thomas Newsom-Davis, Silvia von Karstedt, Jonathan D. Graves, Henning Walczak

ImmunologyImmune Checkpoint InhibitorTrail-r2-specific AntibodiesAntibody EngineeringTumor TargetingCancer CellsImmunotherapyMedicineCell BiologyRecombinant TrailTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1